Background: Mesenchymal stem cells (MSCs) have gained remarkable attention because of
their ability to dualistically regulate tumor growth. The main objective of this study was to …

Our recent study showed that human mesenchymal stem/stromal cells (hMSCs) are
activated to express tumor necrosis factor (TNF)-α-related apoptosis-inducing ligand (TRAIL) …

Human mesenchymal stem cells hold promise as gene therapy vectors for delivery of
various genes to solid tumors for either therapeutic or tumor-tracing purposes. However …

Gene modified or cytokine activated mesenchymal stem cells (MSCs) have been used as a
treatment in various types of cancer. Moreover, irradiation is usually applied as either a …

Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer with poor
prognosis. Despite the emergence of new and targeted therapies for other types of breast …

Stem cell based treatments are being increasingly explored for their possible potential to
treat various cancers. Mesenchymal stem cells believed to possess anti-tumor potential and …

Background: Mesenchymal stem cells (MSCs) have attracted great interest in cancer therapy
since the discovery of their tumor tropism. This study was performed to investigate the effects …

Background aims Previously, we showed that human mesenchymal stromal cells (hMSCs)
were activated to express tumor necrosis factor (TNF)-related apoptosis-inducing ligand …

Background: Breast cancer (BC) is the leading cause of death cancer in women. Cancer
therapies using TNFα and IFNγ have been recently developed by direct effects and …

Tumor-necrosis-factor-associated apoptosis-inducing ligand (TRAIL) is one of the most
promising therapeutic cytokines that selectively induce apoptosis in tumor cells. It is known …